Advocating for Access to Oral Myeloma Treatments

Published on

Topics include: Treatments

There have been several recent FDA approvals in myeloma-- all of which are oral medications. But what if your doctor suggests a medication for you and your insurance won't cover it? Unfortunately many patients experience this throughout the US...and throughout the world. Meghan Buzby, Director of US Advocacy for the International Myeloma Foundation, discusses the obstacles to accessing myeloma treatment and explain what patients can do to make a difference. 

View more programs featuring

Related Programs

Targeted Myeloma Treatments Bring Hope for Fewer Side Effects and Curative Therapy

Dr. James Berenson discusses the importance of using maintenance therapies with limited side effects and explores targeted treatments that increase the hope for a curative therapy within the next few years.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on September 3, 2014